摘要
现代高发的子宫肌瘤疾病属于中医学“癥瘕”范畴,历代医家多认为“血瘀”是癥瘕的主要病机,目前,活血化瘀法已成为临床治疗子宫肌瘤的主要治法。本文从中医学对子宫肌瘤病因、病机的认识入手,结合现代医学对活血化瘀方的研究,阐述了活血化瘀法治疗子宫肌瘤的理论依据及主要机制。
Uterine fibroids with high incidence in modern times is a disease of abdominal mass in TCM,and doctors of past dynasties mostly believe that blood stasis is the main pathogenesis of abdominal mass.Therefore,activating blood and resolving stasis has become the main method in the clinical treatment of uterine fibroids.According to the TCM understanding about the etiology and pathogenesis of uterine fibroids and the modern studies of prescriptions for activating blood and resolving stasis,this article elaborates on the theoretical basis and main mechanism of treating uterine fibroids by activating blood and resolving stasis.
作者
史莎莎
余成浩
SHI Shasha;YU Chenghao(Shaanxi University of Chinese Medicine,Xianyang 712046,China;State Key Laboratory of Southwestern Chinese Medicine Resources,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China)
出处
《世界中医药》
CAS
北大核心
2024年第5期753-757,共5页
World Chinese Medicine
基金
国家自然科学基金项目(81673878)——“三棱-莪术”组分配伍干预子宫肌瘤细胞增殖的基质成纤维细胞活化机制研究
四川省科技计划项目(2020JDTD0022)——活血化瘀方药防治妇科肿瘤的物质基础与作用机理研究。
关键词
活血化瘀法
子宫肌瘤
病因
病机
血瘀
癥瘕
Method of activating blood and resolving stasis
Uterine fibroids
Etiology
Pathogenesis
Blood stasis
Abdominal mass
